Correlation Between Telkom Indonesia and Reata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Telkom Indonesia and Reata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telkom Indonesia and Reata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telkom Indonesia Tbk and Reata Pharmaceuticals, you can compare the effects of market volatilities on Telkom Indonesia and Reata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telkom Indonesia with a short position of Reata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telkom Indonesia and Reata Pharmaceuticals.
Diversification Opportunities for Telkom Indonesia and Reata Pharmaceuticals
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Telkom and Reata is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Telkom Indonesia Tbk and Reata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reata Pharmaceuticals and Telkom Indonesia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telkom Indonesia Tbk are associated (or correlated) with Reata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reata Pharmaceuticals has no effect on the direction of Telkom Indonesia i.e., Telkom Indonesia and Reata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Telkom Indonesia and Reata Pharmaceuticals
Considering the 90-day investment horizon Telkom Indonesia Tbk is expected to under-perform the Reata Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Telkom Indonesia Tbk is 12.17 times less risky than Reata Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Reata Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 3,776 in Reata Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 7,191 from holding Reata Pharmaceuticals or generate 190.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 31.72% |
| Values | Daily Returns |
Telkom Indonesia Tbk vs. Reata Pharmaceuticals
Performance |
| Timeline |
| Telkom Indonesia Tbk |
| Reata Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Telkom Indonesia and Reata Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Telkom Indonesia and Reata Pharmaceuticals
The main advantage of trading using opposite Telkom Indonesia and Reata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telkom Indonesia position performs unexpectedly, Reata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reata Pharmaceuticals will offset losses from the drop in Reata Pharmaceuticals' long position.| Telkom Indonesia vs. Liberty Broadband Srs | Telkom Indonesia vs. Ribbon Communications | Telkom Indonesia vs. Liberty Broadband Srs | Telkom Indonesia vs. Shenandoah Telecommunications Co |
| Reata Pharmaceuticals vs. Sarepta Therapeutics | Reata Pharmaceuticals vs. Krystal Biotech | Reata Pharmaceuticals vs. PTC Therapeutics | Reata Pharmaceuticals vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |